Potential Role of HMGCS2 in Tumor Angiogenesis in Colorectal Cancer and Its Potential Use as a Diagnostic Marker

Table 1

The characteristic of patients with colorectal cancer.

Variables	Number of patients (%)	β-hydroxybutyrate (mean ± SEM)∗
Total	80
Age
<=50 years	19 (46.25%)	0.2458 ± 0.0612
>50 years	61 (53.75%)	0.3475 ± 0.0615
Gender
Male	45 (56.25%)	0.2929 ± 0.0477
Female	35 (43.75%)	0.3471 ± 0.0794
Stage
I	12 (15%)	0.0900±0.0427
II	39 (48.75%)	0.1700±0.0802
III	24 (30%)	0.1900±0.0726
IV	5 (6.25%)	0.330±0.2874

∗Normal level is 0.03-0.3.